339 related articles for article (PubMed ID: 32494659)
1. Tumor microenvironment-activatable Fe-doxorubicin preloaded amorphous CaCO
Xue CC; Li MH; Zhao Y; Zhou J; Hu Y; Cai KY; Zhao Y; Yu SH; Luo Z
Sci Adv; 2020 May; 6(18):eaax1346. PubMed ID: 32494659
[TBL] [Abstract][Full Text] [Related]
2. Activatable Biomineralized Nanoplatform Remodels the Intracellular Environment of Multidrug-Resistant Tumors for Enhanced Ferroptosis/Apoptosis Therapy.
Wang X; Zhao Y; Hu Y; Fei Y; Zhao Y; Xue C; Cai K; Li M; Luo Z
Small; 2021 Nov; 17(47):e2102269. PubMed ID: 34554637
[TBL] [Abstract][Full Text] [Related]
3. Efficient Magnetic Nanocatalyst-Induced Chemo- and Ferroptosis Synergistic Cancer Therapy in Combination with T
Zhu L; Wang J; Tang X; Zhang C; Wang P; Wu L; Gao W; Ding W; Zhang G; Tao X
ACS Appl Mater Interfaces; 2022 Jan; 14(3):3621-3632. PubMed ID: 35005898
[TBL] [Abstract][Full Text] [Related]
4. Ferrous ions doped calcium carbonate nanoparticles potentiate chemotherapy by inducing ferroptosis.
Han Y; Dong Z; Wang C; Li Q; Hao Y; Yang Z; Zhu W; Zhang Y; Liu Z; Feng L
J Control Release; 2022 Aug; 348():346-356. PubMed ID: 35679965
[TBL] [Abstract][Full Text] [Related]
5. Functionalized Fe-Doped Carbon Dots Exhibiting Dual Glutathione Consumption to Amplify Ferroptosis for Enhanced Cancer Therapy.
Zhou M; Yang Z; Yin T; Zhao Y; Wang CY; Zhu GY; Bai LP; Jiang ZH; Zhang W
ACS Appl Mater Interfaces; 2023 Nov; 15(46):53228-53241. PubMed ID: 37943281
[TBL] [Abstract][Full Text] [Related]
6. Engineering magnetotactic bacteria MVs to synergize chemotherapy, ferroptosis and immunotherapy for augmented antitumor therapy.
Jiang G; Xiang Z; Fang Q
Nanoscale Horiz; 2023 Jul; 8(8):1062-1072. PubMed ID: 37306000
[TBL] [Abstract][Full Text] [Related]
7. A tumor microenvironment responsive nanoplatform with oxidative stress amplification for effective MRI-based visual tumor ferroptosis.
Luo S; Ma D; Wei R; Yao W; Pang X; Wang Y; Xu X; Wei X; Guo Y; Jiang X; Yuan Y; Yang R
Acta Biomater; 2022 Jan; 138():518-527. PubMed ID: 34775124
[TBL] [Abstract][Full Text] [Related]
8. Self-amplification of oxidative stress with tumour microenvironment-activatable iron-doped nanoplatform for targeting hepatocellular carcinoma synergistic cascade therapy and diagnosis.
Zhou QM; Lu YF; Zhou JP; Yang XY; Wang XJ; Yu JN; Du YZ; Yu RS
J Nanobiotechnology; 2021 Nov; 19(1):361. PubMed ID: 34749740
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional Fe-based coordination polymer nano-bomb modified with β-lapachone and CaO
Zhao P; Gong L; Chang L; Du H; Geng M; Meng S; Dai L
J Nanobiotechnology; 2024 Jan; 22(1):3. PubMed ID: 38166978
[TBL] [Abstract][Full Text] [Related]
10. Amorphous ferric oxide-coating selenium core-shell nanoparticles: a self-preservation Pt(IV) platform for multi-modal cancer therapies through hydrogen peroxide depletion-mediated anti-angiogenesis, apoptosis and ferroptosis.
Xu Z; Li Q; Zhang C; Wang P; Xu X; Ran L; Zhang L; Tian G; Zhang G
Nanoscale; 2022 Aug; 14(32):11600-11611. PubMed ID: 35861683
[TBL] [Abstract][Full Text] [Related]
11. A Fe(III)-porphyrin-oxaliplatin(IV) nanoplatform for enhanced ferroptosis and combined therapy.
Hu X; Li R; Wu W; Fang K; Zhu Z; Wang Y; Zhou L; Chen M; Dong C; Shi S
J Control Release; 2022 Aug; 348():660-671. PubMed ID: 35716884
[TBL] [Abstract][Full Text] [Related]
12. A Versatile Supramolecular Assembly Platform for Tumor Microenvironment Motivated Drug Release and Ferroptosis Synergistic Therapy.
Liu D; Lin M; Shu L; Sun J; Chen X
Nano Lett; 2023 Jun; 23(12):5713-5721. PubMed ID: 37313864
[TBL] [Abstract][Full Text] [Related]
13. Iron-doped cross-linked lipoic acid nano-aggregates for ferroptosis-mediated cancer treatment.
Tan J; Zhou X; Zhang S
Acta Biomater; 2023 Mar; 159():289-299. PubMed ID: 36706854
[TBL] [Abstract][Full Text] [Related]
14. Oxygen Self-Generating Nanoreactor Mediated Ferroptosis Activation and Immunotherapy in Triple-Negative Breast Cancer.
Li K; Xu K; He Y; Yang Y; Tan M; Mao Y; Zou Y; Feng Q; Luo Z; Cai K
ACS Nano; 2023 Mar; 17(5):4667-4687. PubMed ID: 36861638
[TBL] [Abstract][Full Text] [Related]
15. Activatable nanomedicine for overcoming hypoxia-induced resistance to chemotherapy and inhibiting tumor growth by inducing collaborative apoptosis and ferroptosis in solid tumors.
Fu J; Li T; Yang Y; Jiang L; Wang W; Fu L; Zhu Y; Hao Y
Biomaterials; 2021 Jan; 268():120537. PubMed ID: 33260096
[TBL] [Abstract][Full Text] [Related]
16. A preloaded amorphous calcium carbonate/doxorubicin@silica nanoreactor for pH-responsive delivery of an anticancer drug.
Zhao Y; Luo Z; Li M; Qu Q; Ma X; Yu SH; Zhao Y
Angew Chem Int Ed Engl; 2015 Jan; 54(3):919-22. PubMed ID: 25422068
[TBL] [Abstract][Full Text] [Related]
17. Nanolongan with Multiple On-Demand Conversions for Ferroptosis-Apoptosis Combined Anticancer Therapy.
Bao W; Liu X; Lv Y; Lu GH; Li F; Zhang F; Liu B; Li D; Wei W; Li Y
ACS Nano; 2019 Jan; 13(1):260-273. PubMed ID: 30616348
[TBL] [Abstract][Full Text] [Related]
18. Iron-doxorubicin prodrug loaded liposome nanogenerator programs multimodal ferroptosis for efficient cancer therapy.
Yang Y; Zuo S; Li L; Kuang X; Li J; Sun B; Wang S; He Z; Sun J
Asian J Pharm Sci; 2021 Nov; 16(6):784-793. PubMed ID: 35027953
[TBL] [Abstract][Full Text] [Related]
19. Smart biomimetic metal organic frameworks based on ROS-ferroptosis-glycolysis regulation for enhanced tumor chemo-immunotherapy.
Yang J; Ma S; Xu R; Wei Y; Zhang J; Zuo T; Wang Z; Deng H; Yang N; Shen Q
J Control Release; 2021 Jun; 334():21-33. PubMed ID: 33872626
[TBL] [Abstract][Full Text] [Related]
20. Tumor-acidity and bioorthogonal chemistry-mediated construction and deconstruction of drug depots for ferroptosis under normoxia and hypoxia.
Zhou J; Wang K; Jiang M; Li J; Yuan Y
Acta Biomater; 2022 Apr; 142():253-263. PubMed ID: 35085800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
